Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

AOD-9604.

Research draft

AOD-9604 is a modified fragment of human growth hormone investigated for metabolic effects.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

AOD-9604 is a modified fragment of human growth hormone investigated for metabolic effects.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFO16 amino acids
PRIMARY CONTEXTGrowth hormone fragment (177–191)

Mechanism

It was designed to reproduce selected effects on fat metabolism without the full growth-hormone molecule.

Human research

Historical obesity studies exist, but they do not establish an effective contemporary injectable weight-loss treatment.

Preclinical & other research

Laboratory work examined fat breakdown and metabolic responses; these findings cannot establish human weight loss.

Safety & unknowns

Human safety evidence is limited, particularly for current injectable products.

Regulatory status

Research compound; a compounding assessment is not medicine approval.

Reported use & evidence

Research profile draft

The supplied AOD-9604 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds